Medication info
K-BARO tablet 4 mg (Pitavastatin Calcium Hydrate)

K-BARO tablet 4 mg (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›4.409mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
Light yellow round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202103313 · Approved 2021.04.22

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose in adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goals, and patient response. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated apo-B protein
  • elevated triglyceride level
View approved original text

This medication helps lower total cholesterol, LDL cholesterol, apo-B protein, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It also increases HDL cholesterol levels, improving blood lipid balance. It is more effective when used alongside dietary interventions and contributes to reducing cardiovascular disease risk. Therefore, it plays a significant role in managing hyperlipidemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose in adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goals, and patient response. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medication should not be used in patients with allergies to specific ingredients or with impaired liver function. It should also be avoided in cases of active liver disease or persistently elevated liver enzyme levels. Patients with severe liver impairment or bile duct obstruction, as well as those taking the immunosuppressive drug cyclosporine, should not use this medication. It is also contraindicated in women with myopathy, those who are pregnant or may become pregnant, and breastfeeding women. Safety has not been established in pediatric patients, thus it should not be administered to children. This medication contains lactose, so it should not be taken by those with lactose intolerance or specific genetic metabolic disorders. Patients allergic to soybean oil, soy, peanuts, and other allergens should exercise caution. Patients with kidney dysfunction, a history of liver disease, or excessive alcohol consumption should use this medication cautiously. The risk of muscle damage may increase when combined with fibrate medications or niacin, so co-administration should be avoided or closely monitored. Patients with hypothyroidism, hereditary muscle diseases, elderly patients, and those with lipid metabolism disorders should also exercise caution when using this medication. This medication can cause various adverse reactions such as myalgia, muscle weakness, liver function abnormalities, skin rash, and dyspepsia, so consult a doctor immediately if any symptoms appear. In particular, symptoms like myalgia, weakness, or changes in urine color may indicate a serious condition called rhabdomyolysis, and administration should be stopped immediately. During treatment, regular blood tests should monitor liver function and muscle condition, and if there is no therapeutic effect, use of the medication should be discontinued. This medication may interact with other drugs, so be sure to inform healthcare providers of any other medications being taken. Elderly patients may experience adverse reactions more easily due to decreased body function, so dosage adjustments and monitoring are recommended. Pregnant or breastfeeding women should absolutely not take this medication as it may harm the fetus or infant. This medication should be swallowed whole without breaking the tablet and stored out of reach of children.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 82 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • increased γ-GT
  • elevated ALP
  • increased LDH
  • rigidity
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • thirst
  • indigestion
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • polyuria
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • elevated aldosterone
  • increased adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • weakness
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • taste disturbances
  • positive antinuclear antibody
  • sleep disorders
  • amnesia
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes mellitus
  • immune-mediated necrotizing myopathy
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • asthenia
  • nausea
  • thrombocytopenia
  • increased serum creatinine

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in a tight container that protects against light. Additionally, it is best to store the medication at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Light yellow round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.